CN1615938A - 一种治疗急性缺血性脑卒中的药剂及其制备方法 - Google Patents
一种治疗急性缺血性脑卒中的药剂及其制备方法 Download PDFInfo
- Publication number
- CN1615938A CN1615938A CN 200410012533 CN200410012533A CN1615938A CN 1615938 A CN1615938 A CN 1615938A CN 200410012533 CN200410012533 CN 200410012533 CN 200410012533 A CN200410012533 A CN 200410012533A CN 1615938 A CN1615938 A CN 1615938A
- Authority
- CN
- China
- Prior art keywords
- injection
- butyphthalide
- emulsifier
- water
- excipient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010008190 Cerebrovascular accident Diseases 0.000 title claims abstract description 16
- 208000006011 Stroke Diseases 0.000 title claims abstract description 16
- 239000003814 drug Substances 0.000 title claims abstract description 15
- 230000002490 cerebral effect Effects 0.000 title claims abstract description 14
- 230000001154 acute effect Effects 0.000 title claims abstract description 13
- 230000000302 ischemic effect Effects 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title description 4
- 229940079593 drug Drugs 0.000 title description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000002347 injection Methods 0.000 claims abstract description 17
- 239000007924 injection Substances 0.000 claims abstract description 17
- 239000008215 water for injection Substances 0.000 claims abstract description 17
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 13
- 239000007957 coemulsifier Substances 0.000 claims abstract description 12
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 239000000243 solution Substances 0.000 claims abstract description 8
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 238000010438 heat treatment Methods 0.000 claims abstract description 5
- 238000005303 weighing Methods 0.000 claims abstract description 4
- HJXMNVQARNZTEE-UHFFFAOYSA-N Butylphthalide Chemical compound C1=CC=C2C(CCCC)OC(=O)C2=C1 HJXMNVQARNZTEE-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 229950005197 butylphthalide Drugs 0.000 claims description 7
- 238000012856 packing Methods 0.000 claims description 7
- ZPIKVDODKLJKIN-NSHDSACASA-N Senkyunolide Chemical compound C1CC=CC2=C1[C@H](CCCC)OC2=O ZPIKVDODKLJKIN-NSHDSACASA-N 0.000 claims description 6
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 239000008347 soybean phospholipid Substances 0.000 claims description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 239000003610 charcoal Substances 0.000 claims description 3
- 238000005262 decarbonization Methods 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 229920001983 poloxamer Polymers 0.000 claims description 3
- 229960000502 poloxamer Drugs 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 230000006340 racemization Effects 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 5
- 229920001993 poloxamer 188 Polymers 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 abstract description 7
- OCKPCBLVNKHBMX-UHFFFAOYSA-N butylbenzene Chemical compound CCCCC1=CC=CC=C1 OCKPCBLVNKHBMX-UHFFFAOYSA-N 0.000 abstract 4
- 238000002156 mixing Methods 0.000 abstract 2
- 238000009775 high-speed stirring Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000005516 engineering process Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 206010008118 cerebral infarction Diseases 0.000 description 5
- 201000006474 Brain Ischemia Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007901 soft capsule Substances 0.000 description 4
- 206010008120 Cerebral ischaemia Diseases 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000001387 apium graveolens Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010060840 Ischaemic cerebral infarction Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410012533 CN1290491C (zh) | 2004-09-20 | 2004-09-20 | 一种治疗急性缺血性脑卒中的药剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410012533 CN1290491C (zh) | 2004-09-20 | 2004-09-20 | 一种治疗急性缺血性脑卒中的药剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1615938A true CN1615938A (zh) | 2005-05-18 |
CN1290491C CN1290491C (zh) | 2006-12-20 |
Family
ID=34763260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410012533 Active CN1290491C (zh) | 2004-09-20 | 2004-09-20 | 一种治疗急性缺血性脑卒中的药剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1290491C (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007068212A1 (fr) * | 2005-12-16 | 2007-06-21 | Shijiazhuang Pharma Group Nbp Pharmaceutical Co., Ltd. | Emulsion intraveineuse de butylbenzene phtaleine et son application |
WO2007073682A1 (en) * | 2005-12-24 | 2007-07-05 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Dropping pill of butylbenzene phthalein and its application |
CN103505409A (zh) * | 2012-06-27 | 2014-01-15 | 石药集团中奇制药技术(石家庄)有限公司 | 一种丁苯酞注射液及其制备方法 |
CN104721166A (zh) * | 2013-12-21 | 2015-06-24 | 石药集团恩必普药业有限公司 | 一种丁基苯酞液体硬胶囊制剂及其制备方法 |
CN109419800A (zh) * | 2017-08-30 | 2019-03-05 | 石药集团恩必普药业有限公司 | 药物组合物及其应用 |
CN109528709A (zh) * | 2018-12-03 | 2019-03-29 | 新乡医学院 | 丁苯酞在急性酒精中毒引起脑内海马γ网络振荡保护中的应用 |
CN110856712A (zh) * | 2018-08-06 | 2020-03-03 | 刘超 | 丁苯酞自微乳组合物及其制备方法和用途 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116251093A (zh) * | 2017-12-29 | 2023-06-13 | 石药集团恩必普药业有限公司 | 一种包含丁苯酞制剂的药物产品 |
-
2004
- 2004-09-20 CN CN 200410012533 patent/CN1290491C/zh active Active
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10463614B2 (en) | 2005-12-16 | 2019-11-05 | Shijiazhuang Pharma Group Nbp Pharmaceutical Co. | Butylphthalide intravenous emulsion and application thereof |
EA014518B1 (ru) * | 2005-12-16 | 2010-12-30 | СиЭсПиСи ЭнБиПи ФАРМАСЬЮТИКЛ КО., ЛТД. | Эмульсия бутилфталида для внутривенного введения и ее применение |
KR101061268B1 (ko) | 2005-12-16 | 2011-08-31 | 씨에스피씨 엔비피 파마슈티컬 컴퍼니 리미티드 | 뷰틸프탈라이드 정맥주사용 유탁액 및 이의 용도 |
WO2007068212A1 (fr) * | 2005-12-16 | 2007-06-21 | Shijiazhuang Pharma Group Nbp Pharmaceutical Co., Ltd. | Emulsion intraveineuse de butylbenzene phtaleine et son application |
WO2007073682A1 (en) * | 2005-12-24 | 2007-07-05 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Dropping pill of butylbenzene phthalein and its application |
CN107970208B (zh) * | 2012-06-27 | 2021-01-19 | 石药集团中奇制药技术(石家庄)有限公司 | 一种丁苯酞注射液及其制备方法 |
CN103505409A (zh) * | 2012-06-27 | 2014-01-15 | 石药集团中奇制药技术(石家庄)有限公司 | 一种丁苯酞注射液及其制备方法 |
CN107970208A (zh) * | 2012-06-27 | 2018-05-01 | 石药集团中奇制药技术(石家庄)有限公司 | 一种丁苯酞注射液及其制备方法 |
CN104721166A (zh) * | 2013-12-21 | 2015-06-24 | 石药集团恩必普药业有限公司 | 一种丁基苯酞液体硬胶囊制剂及其制备方法 |
CN109419800B (zh) * | 2017-08-30 | 2021-04-30 | 石药集团恩必普药业有限公司 | 药物组合物及其应用 |
CN109419800A (zh) * | 2017-08-30 | 2019-03-05 | 石药集团恩必普药业有限公司 | 药物组合物及其应用 |
CN110856712A (zh) * | 2018-08-06 | 2020-03-03 | 刘超 | 丁苯酞自微乳组合物及其制备方法和用途 |
CN110856712B (zh) * | 2018-08-06 | 2021-11-30 | 刘超 | 丁苯酞自微乳组合物及其制备方法和用途 |
CN109528709A (zh) * | 2018-12-03 | 2019-03-29 | 新乡医学院 | 丁苯酞在急性酒精中毒引起脑内海马γ网络振荡保护中的应用 |
CN114796199A (zh) * | 2018-12-03 | 2022-07-29 | 新乡医学院 | 丁苯酞在急性酒精中毒引起脑内海马γ网络振荡保护中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1290491C (zh) | 2006-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101411710B (zh) | 培美曲塞二钠冻干粉针剂及其制备方法 | |
CN102871959A (zh) | 稳定的(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺药物组合物 | |
CN1899323A (zh) | 一种银杏叶提取物、含有该提取物的注射剂及其制备方法 | |
CN1290491C (zh) | 一种治疗急性缺血性脑卒中的药剂及其制备方法 | |
CN1891211A (zh) | 一种姜黄素冻干脂质体的制备方法 | |
CN107303277B (zh) | 骨靶向脂质体、其药物和制剂及其制备方法与应用 | |
CN1660029A (zh) | 一种制备滴丸的新工艺及其专用的滴头装置 | |
CN112891559B (zh) | 促进牙髓干细胞增殖和成骨分化的多肽共修饰柚皮苷纳米脂质体及其制备方法和用途 | |
CN1931139A (zh) | 注射用盐酸川芎嗪冻干剂及其制备方法 | |
CN1827096A (zh) | 含壳聚糖衍生物的多西他塞脂质体、冻干制剂及制备方法 | |
CN103494780B (zh) | 一种注射用加米霉素组合物冻干粉及制备方法 | |
CN105418731B (zh) | 鹿茸蛋白提取物及其药学用途 | |
CN110464835B (zh) | 一种胰岛素柔性微粒及其制剂 | |
CN101028250A (zh) | 藤黄酸脂质体及其冻干粉针剂与制备方法 | |
CN109481396A (zh) | 一种富勒烯水溶液、注射剂及其制备方法 | |
CN100348198C (zh) | 单唾液酸四已糖神经节苷脂脂质体复合物制剂 | |
CN101439083A (zh) | 具有清风热、通鼻窍的中药软胶囊剂及其制备方法和质量控制方法 | |
CN103040767A (zh) | 稳定的注射用穿琥宁冷冻干燥粉针剂 | |
CN110339341A (zh) | 一种达托霉素或其盐的组合物 | |
CN1843368B (zh) | 一种灯盏花素长循环纳米脂质体及其制备方法 | |
CN1582932A (zh) | 羟基喜树碱脂质体及其制备方法 | |
CN102188379A (zh) | 载药脂质体的制备方法 | |
CN113616596B (zh) | 一种紫杉醇脂质体药物组合物及其制备方法 | |
CN1562000A (zh) | 4-羟基-2-氧代-1-吡咯烷乙酰胺冻干制剂及其制备方法 | |
CN102988423B (zh) | 一种复方骨肽脂质体注射剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SYSCAN MICRO PHOTOELECTRIC TECHNOLOGY (SHENZHEN) Free format text: FORMER OWNER: ZHOU GUIRONG Effective date: 20070511 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20070511 Address after: 050051 No. 276 West Zhongshan Road, Hebei, Shijiazhuang Patentee after: Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. of CSPC Group Address before: 050051 No. 276 West Zhongshan Road, Hebei, Shijiazhuang Patentee before: Zhou Guirong |
|
ASS | Succession or assignment of patent right |
Owner name: ENBIPU PHARMACY CO., LTD., SHIYAO GROUP. Effective date: 20130320 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 050051 SHIJIAZHUANG, HEBEI PROVINCE TO: 050035 SHIJIAZHUANG, HEBEI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130320 Address after: 050035 No. 226 the Yellow River Avenue, Shijiazhuang hi tech Development Zone, Hebei Patentee after: Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. of CSPC Group Patentee after: Enbipu Pharmacy Co., Ltd., Shiyao Group. Address before: 050051 No. 276 West Zhongshan Road, Hebei, Shijiazhuang Patentee before: Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. of CSPC Group |